Aragen Biologics Profile
Key Indicators
- Authorised Capital ₹ 245.00 Cr
- Paid Up Capital ₹ 146.00 Cr
- Company Age 1 Year 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 140.00 Cr
About Aragen Biologics
Aragen Biologics Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2023 (One year and eight months 18 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 245.00 Cr and a paid-up capital of Rs 146.00 Cr.
The company currently has active open charges totaling ₹140.00 Cr.
Manmahesh Kantipudi and Gunapati Keshav serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U21001TS2023PTC174243
- Company No.
174243
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2023
- Date of AGM
24 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Aragen Biologics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manmahesh Kantipudi  | Director | 21-Jun-2023 | Current |
| Gunapati Keshav | Director | 21-Jun-2023 | Current |
Financial Performance of Aragen Biologics.
Aragen Biologics Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aragen Biologics?
In 2024, Aragen Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zeroharm Sciences Private LimitedManmahesh Kantipudi is a mutual person
Aragen Life Sciences LimitedManmahesh Kantipudi and Gunapati Keshav are mutual person
Aavishkar Oral Strips Private LimitedGunapati Keshav is a mutual person
- Aragen Foundation
Manmahesh Kantipudi and Gunapati Keshav are mutual person
Intox Private LimitedManmahesh Kantipudi is a mutual person
Zeroharm Prerna Private LimitedManmahesh Kantipudi is a mutual person
Charges (Loans)
Open Charges
₹140.00 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 140.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2024 | Citi Bank N.A. | ₹120.00 Cr | Open |
| 30 May 2024 | Citi Bank N.A. | ₹20.00 Cr | Open |
How Many Employees Work at Aragen Biologics?
Unlock and access historical data on people associated with Aragen Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aragen Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aragen Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aragen Biologics
Recent activity within the organization
- Charges
A charge with Citi Bank N.A. amounted to Rs. 120.00 Cr with Charge ID 100936154 was registered on 30 May 2024.
- Charges
A charge with Citi Bank N.A. amounted to Rs. 20.00 Cr with Charge ID 100936171 was registered on 30 May 2024.
- Annual General Meeting
Aragen Biologics Private Limited last Annual general meeting of members was held on 24 May 2024 as per latest MCA records.
- Balance Sheet
Aragen Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Manmahesh Kantipudi was appointed as a Director was appointed as a Director on 21 Jun 2023 & has been associated with this company since 1 year 8 months .
- Director Appointment
Gunapati Reddy Venkat Keshav was appointed as a Director was appointed as a Director on 21 Jun 2023 & has been associated with this company since 1 year 8 months .
Recent News, Updates & Announcement
Hyderabad's Pharma Industry Thrives with Aragen's Rs 2000 Cr Investment and 1500 New Jobs, Thanks to CM Revanth Reddy's Leadership.Hyderabad is getting a big boost in the pharma industry with Aragen Life Sciences investing Rs 2000 crore and creating 1500 jobs. This will make the city a top destination for drug discovery and development. CM Revanth Reddy's leadership is attracting big investments and showcasing our talent. Aragen's CEO is confident in Hyderabad's potential and plans to invest for the next 5 years..
Frequently asked questions
What is the Incorporation or founding date of Aragen Biologics Private Limited?
Aragen Biologics Private Limited was incorporated on 21 Jun 2023.
What is authorized share capital and paid-up capital of Aragen Biologics Private Limited?
The authorized share capital of Aragen Biologics Private Limited is ₹ 245.00 Cr and paid-up capital is ₹ 146.00 Cr.
Who are the current board members & directors of Aragen Biologics Private Limited?
Currently 2 directors are associated with Aragen Biologics Private Limited.
- Manmahesh Kantipudi
- Gunapati Reddy Venkat Keshav
What is the registered address of Aragen Biologics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aragen Biologics Private Limited is Plot No. 28A Ida Nacharam India, Uppal, Telangana, 500076.
What is the corporate identification number (CIN) and company number of Aragen Biologics Private Limited?
The corporate identification number (CIN) of Aragen Biologics Private Limited is U21001TS2023PTC174243 and the company number is 174243 as per Ministry of Corporate Affairs (MCA).
What is the official website of Aragen Biologics Private Limited?
The Official website of Aragen Biologics Private Limited is https://www.aragen.com
What are the total open charges for Aragen Biologics Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Aragen Biologics Private Limited amount to ₹ 140.00 Cr.
When was the last Balance Sheet of Aragen Biologics Private Limited filed with the ROC?
The most recent Balance Sheet for Aragen Biologics Private Limited was filed with the ROC on 31 Mar 2024.